NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 184 filers reported holding NEVRO CORP in Q3 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $586,580 | -90.9% | 12,600 | -76.8% | 0.00% | -92.3% |
| Q2 2020 | $6,476,000 | -21.4% | 54,200 | -34.2% | 0.01% | -38.1% |
| Q1 2020 | $8,238,000 | -33.0% | 82,400 | -21.2% | 0.02% | -16.0% |
| Q4 2019 | $12,294,000 | +576.6% | 104,600 | +318.4% | 0.02% | +177.8% |
| Q4 2016 | $1,817,000 | -42.9% | 25,000 | -18.0% | 0.01% | -35.7% |
| Q3 2016 | $3,184,000 | – | 30,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |